EW stock is on investors' radar courtesy to the promising structural heart opportunities post the divestment of the Critical Care arm.

Edward Lifesciences remains a "Hold" as it trades close to its intrinsic value, despite improved fundamentals and solid third ...

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...

Wedgewood Partners, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter ...

P.E.I. Nurses' Union welcomes the recent change to the Canada Health Act, which will allow nurse practitioners to contribute ...

Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, is a company that specializes in innovative ...

IRVINE, Calif., September 03, 2024--Edwards Lifesciences (NYSE: EW) has successfully completed the sale of its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX) for $4.2 ...

IRVINE, Calif., September 03, 2024--Edwards Lifesciences (NYSE: EW) has successfully completed the sale of its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX) for $4.2 ...

As NAMI approaches its fiftieth anniversary as the nation’s largest grassroots mental health advocacy organization, NAMI’s ...

IRVINE, Calif., September 03, 2024--Edwards Lifesciences (NYSE: EW) has successfully completed the sale of its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX ...